4.6 Review

Acetylsalicylic Acid and Mood Disorders: A Systematic Review

期刊

PHARMACEUTICALS
卷 16, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/ph16010067

关键词

acetylsalicylic acid; aspirin; ASA; mood disorders; bipolar disorder; major depression; depressive episode; mania; animal model of mania; animal model of depression

向作者/读者索取更多资源

This study systematically summarizes the current knowledge on the effects of ASA on mood disorders and inflammatory parameters. Low-dose ASA was found to be safe and effective in treating all types of affective episodes in mood disorders. Observational studies showed a reduced risk of affective episodes in chronic low-dose ASA users. Although an association between ASA response and inflammatory parameters was found in preclinical studies, this was not confirmed in clinical trials. Further research is needed to evaluate the safety and efficacy of ASA in recurrent mood disorders and its relationship with inflammatory phenotype and cytokines.
The effects of acetylsalicylic acid (ASA) on mood disorders (MD) and on inflammatory parameters in preclinical and clinical studies have not yet been comprehensively evaluated. The aim of this study was to systematically summarize the available knowledge on this topic according to PRISMA guidelines. Data from preclinical and clinical studies were analyzed, considering the safety and efficacy of ASA in the treatment of MD and the correlation of inflammatory parameters with the effect of ASA treatment. Twenty-one studies were included. Both preclinical and clinical studies found evidence indicating the safety and efficacy of low-dose ASA in the treatment of all types of affective episodes in MD. Observational studies have indicated a reduced risk of all types of affective episodes in chronic low-dose ASA users (HR 0.92, 95% CI: 0.88, 0.95, p < 0.0001). An association between ASA response and inflammatory parameters was found in preclinical studies, but this was not confirmed in clinical trials. Further long-term clinical trials evaluating the safety and efficacy of ASA in recurrent MD, as well as assessing the linkage of ASA treatment with inflammatory phenotype and cytokines, are required. There is also a need for preclinical studies to understand the exact mechanism of action of ASA in MD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据